Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor α1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase

Molecular Endocrinology

Volumn 19, Issue 6, 2005, Pages 1618-1628

  Kinugawa, Koichiro ^d   Jeong, Mark Y ^c   Bristow, Michael R ^a   Long, Carlin S ^a,b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b Box 0960 ^*  (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RECEPTOR SUBUNIT; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HORMONE BINDING; LIGAND BINDING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CYTOSOL; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; HYPERTROPHY; IMIDAZOLES; IMMUNOPRECIPITATION; INHIBITORY CONCENTRATION 50; LIGANDS; MAP KINASE KINASE KINASES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MUSCLE CELLS; MYOCARDIUM; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTEIN ISOFORMS; PYRIDINES; RABBITS; RATS; RECEPTORS, THYROID HORMONE; RIBONUCLEASES; SIGNAL TRANSDUCTION; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONES; TIME FACTORS;

EID: 22344456267     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0503     Document Type: Article

References (45)

1. Hamilton MA, Stevenson LW, Luu M, Walden JA 1990 Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 16:91-95
2. Opasich C, Pacini F, Ambrosino N, Riccardi PG, Febo O, Ferrari R, Cobelli F, Tavazzi L 1996 Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J 17:1860-1866
3. Fruhwald FM, Ramschak-Schwarzer S, Pichler B, Watzinger N, Schumacher M, Zweiker R, Klein W, Eber B 1997 Subclinical thyroid disorders in patients with dilated cardiomyopathy. Cardiology 88:156-159
4. Ascheim DD, Hryniewicz K 2002 Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid 12:511-515
5. Moruzzi P, Doria E, Agostoni PG, Capacchione V, Sganzerla P 1994 Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol 73:374-378
6. Moruzzi P, Doria E, Agostoni PG 1996 Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med 101:461-467
7. Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD, Hage A 1998 Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 81:443-447
8. Morkin E, Pennock G, Spooner PH, Bahl JJ, Underhill Fox K, Goldman S 2002 Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure. Cardiology 97:218-225
9. Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, Ribeiro RC, Tawadrous MF, Lowes BA, Long CS, Bristow MR 2001 Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation 103:1089-1094
10. Baumann CT, Maruvada P, Hager GL, Yen PM 2001 Nuclear cytoplasmic shuttling by thyroid hormone receptors multiple protein interactions are required for nuclear retention. J Biol Chem 276:11237-11245
11. Bunn CF, Neidig JA, Freidinger KE, Stankiewicz TA, Weaver BS, McGrew J, Allison LA 2001 Nucleocytoplasmic shuttling of the thyroid hormone receptor α. Mol Endocrinol 15:512-533
12. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC 2001 Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89:591-598
13. Deng XF, Rokosh DG, Simpson PC 2000 Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. Circ Res 87:781-788
14. Guo W, Kamiya K, Hojo M, Kodama I, Toyama J 1998 Regulation of Kv4.2 and Kv1.4 K+ channel expression by myocardial hypertrophic factors in cultured newborn rat ventricular cells. J Mol Cell Cardiol 30:1449-1455
15. Chiellini G, Apriletti JW, al Yoshihara H, Baxter JD, Ribeiro RC, Scanlan TS 1998 A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 5:299-306
16. Davies SP, Reddy H, Caivano M, Cohen P 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
17. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K 1995 Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011
18. Qian Y, Commane M, Ninomiya-Tsuji J, Matsumoto K, Li X 2001 IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFκB. J Biol Chem 276:41661-41667
19. Klein I 1990 Thyroid hormone and the cardiovascular system. Am J Med 88:631-637
20. Dillmann WH 1993 Cardiac function in thyroid disease: clinical features and management considerations. Ann Thorac Surg 56:S9-S14; discussion S14-S15
21. Sugden PH 2001 Signalling pathways in cardiac myocyte hypertrophy. Ann Med 33:611-622
22. Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB 2000 Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275:38032-38039
23. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ 1999 Thyroid hormone induces activation of mitogenactivated protein kinase in cultured cells. Am J Physiol 276:C1014-C1024
24. Kyriakis JM, Avruch J 2001 Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869
25. Lee Y, Nadal-Ginard B, Mahdavi V, Izumo S 1997 Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the α-cardiac myosin heavy-chain gene. Mol Cell Biol 17: 2745-2755
26. Moriscot AS, Sayen MR, Hartong R, Wu P, Dillmann WH 1997 Transcription of the rat sarcoplasmic reticulum Ca2+ adenosine triphosphatase gene is increased by 3,5,3′-triiodothyronine receptor isoform-specific interactions with the myocyte-specific enhancer factor-2a. Endocrinology 138:26-32
27. Santalucia T, Moreno H, Palacin M, Yacoub MH, Brand NJ, Zorzano A 2001 A novel functional co-operation between MyoD, MEF2 and TRα1 is sufficient for the induction of GLUT4 gene transcription. J Mol Biol 314: 195-204
28. Kishimoto K, Matsumoto K, Ninomiya-Tsuji J 2000 TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem 275:7359-7364
29. Zhu XG, Hanover JA, Hager GL, Cheng SY 1998 Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J Biol Chem 273: 27058-27063
30. Siebler T, Robson H, Bromley M, Stevens DA, Shalet SM, Williams GR 2002 Thyroid status affects number and localization of thyroid hormone receptor expressing mast cells in bone marrow. Bone 30:259-266
31. Maruvada P, Baumann CT, Hager GL, Yen PM 2003 Dynamic Shuttling and Intranuclear Mobility of Nuclear Hormone Receptors. J Biol Chem 278:12425-12432
32. Gloss B, Trost S, Bluhm W, Swanson E, Clark R, Winkfein R, Janzen K, Giles W, Chassande O, Samarut J, Dillmann W 2001 Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor α or β. Endocrinology 142:544-550
33. Macchia PE, Takeuchi Y, Kawai T, Cua K, Gauthier K, Chassande O, Seo H, Hayashi Y, Samarut J, Murata Y, Weiss RE, Refetoff S 2001 Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor α. Proc Natl Acad Sci USA 98: 349-354
34. Clerk A, Harrison JG, Long CS, Sugden PH 1999 Proinflammatory cytokines stimulate mitogen-activated protein kinase subfamilies, increase phosphorylation of c-Jun and ATF2 and upregulate c-Jun protein in neonatal rat ventricular myocytes. J Mol Cell Cardiol 31: 2087-2099
35. Ng DC, Long CS, Bogoyevitch MA 2001 A role for the ERK and p38 MAPKs in Interleukin-1β-stimulated delayed STAT3 activation, ANF expression and cardiac myocyte morphology. J Biol Chem 276:29490-29498
36. Lowes BD, Minobe W, Abraham WT, Lowes BD, Minobe W, Abraham WT 1997 Changes in gene expression in the intact human heart. Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100:2315-2324
37. Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA 1997 Myosin heavy chain gene expression in human heart failure. J Clin Invest 100:2362-2370
38. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR 2002 Myocardial gene expression in dilated cardiomyopathy treated with β-blocking agents. N Engl J Med 346: 1357-1365
39. Wang Y, Huang S, Sah VP, Ross Jr J, Brown JH, Han J, Chien KR 1998 Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273: 2161-2168
40. Cook SA, Sugden PH, Clerk A 1999 Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol 31:1429-1434
41. Haq S, Choukroun G, Lim H, Tymitz KM, del Monte F, Gwathmey J, Grazette L, Michael A, Hajjar R, Force T, Molkentin JD 2001 Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103: 670-677
42. Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, Volodarsky T, Grover GJ, Baxter JD, Chiellini G, Scanlan TS, Dillmann WH 2000 The thyroid hormone receptor-β-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 141:3057-3064
43. Schaack J, Langer S, Guo X 1995 Efficient selection of recombinant adenoviruses by vectors that express β-galactosidase. J Virol 69:3920-3923
44. Ribeiro RC, Apriletti JW, Yen PM, Chin WW, Baxter JD 1994 Heterodimerization and deoxyribonucleic acidbinding properties of a retinoid X receptor-related factor. Endocrinology 135:2076-2085
45. Patten M, Wang W, Aminololama-Shakeri S, Burson M, Long CS 2000 IL-1β increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes. J Mol Cell Cardiol 32:1341-1352